Minerva Neurosciences, Inc. — Director's Dealing 2017

Jan 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2017-01-03

Reporting Person: Davidson Michael (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-03	Stock Option (Right to Buy)	$11.75	A	145000	Acquired	2027-01-02	Common Stock (145000)	Direct

Footnotes

F1: The shares underlying the option shall vest and become exercisable as to 25% on January 3, 2018; the balance of the shares underlying the option shall vest and become exercisable in 12 successive equal quarterly installments, in each case so long as the Reporting Person provides continuous service to the Issuer on each such date.